BIO

Bio-Rad Laboratories, Inc.

337.47 USD
-1.02 (-0.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bio-Rad Laboratories, Inc. stock is up 6.61% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 59.09% of the previous 44 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 20:42 15 Mar, 2024 320.00 PUT 14 93
08 Feb 16:31 15 Mar, 2024 310.00 PUT 28 46
09 Feb 15:07 15 Mar, 2024 320.00 CALL 14 379
09 Feb 15:07 15 Mar, 2024 320.00 CALL 16 379
09 Feb 15:07 15 Mar, 2024 320.00 CALL 14 379
12 Feb 16:26 15 Mar, 2024 310.00 CALL 10 81
12 Feb 16:26 15 Mar, 2024 310.00 CALL 10 81
12 Feb 16:26 15 Mar, 2024 310.00 CALL 12 81
16 Feb 15:18 15 Mar, 2024 320.00 CALL 10 310
16 Feb 16:14 15 Mar, 2024 330.00 CALL 20 371

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.

  • UBS
    Fri Feb 16, 13:13
    buy
    confirm
  • RBC Capital
    Fri Feb 16, 12:15
    buy
    confirm